The following table summarizes the influenza vaccine products that will be publicly funded in B.C. for the 2023/24 season:
| Product | Intended Ages | Dosing |
| FluLaval® Tetra
|
6 months – 64 years | 1 dose given as 0.5 mL IM* |
Fluzone® Quadrivalent |
6 months – 64 years | 1 dose given as 0.5 mL IM* |
| Fluad® |
65 years of age and older in community If FLUAD is unavailable, FLULAVAL TETRA or FLUZONE QUADRIVALENT should be used. |
1 dose given as 0.5 mL IM |
| FluMist Quadrivalent |
2 – 17 years of age May be offered to those 18-59 years of age who have needle phobia and are unwilling to get another influenza vaccine, provided informed consent includes that QIV provides better protection against influenza for this age group. |
1 dose given as 0.2 mL (0.1 mL in each nostril)* |
| Fluzone® High-dose Quadrivalent | 65 years of age and older who are residents of long-term care, assisted living facilities and First Nations communities | 1 dose given as 0.7 mL IM |
*Children under 9 years of age who have not previously received any seasonal influenza vaccine require 2 doses given 4 weeks apart. If the child has received 1 or more doses in any previous season, only a single dose is required. For children requiring 2 doses within the season, QIIV may be given interchangeably with LAIV-Q with either product used for the 1st or 2nd dose if LAIV-Q is not available.